Stoke Therapeutics's total assets for Q3 2025 were $360.26M, a decrease of -6.31% from the previous quarter. STOK total liabilities were $52.16M for the fiscal quarter, a 5.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.